vs

Side-by-side financial comparison of BIOHARVEST SCIENCES INC. (BHST) and BTCS Inc. (BTCS). Click either name above to swap in a different company.

BIOHARVEST SCIENCES INC. is the larger business by last-quarter revenue ($8.4M vs $7.1M, roughly 1.2× BTCS Inc.).

BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.

BHST vs BTCS — Head-to-Head

Bigger by revenue
BHST
BHST
1.2× larger
BHST
$8.4M
$7.1M
BTCS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BHST
BHST
BTCS
BTCS
Revenue
$8.4M
$7.1M
Net Profit
Gross Margin
60.3%
12.4%
Operating Margin
Net Margin
Revenue YoY
205.5%
Net Profit YoY
EPS (diluted)
$-1.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHST
BHST
BTCS
BTCS
Q4 25
$7.1M
Q3 25
$8.4M
$4.9M
Q2 25
$8.1M
$2.8M
Q1 25
$7.7M
$1.7M
Q4 24
$2.3M
Q3 24
$6.5M
$739.2K
Q2 24
$6.0M
$561.2K
Q1 24
$451.4K
Net Profit
BHST
BHST
BTCS
BTCS
Q4 25
Q3 25
$65.6M
Q2 25
$3.9M
Q1 25
$-17.3M
Q4 24
Q3 24
$-9.0M
Q2 24
$-6.7M
Q1 24
$12.3M
Gross Margin
BHST
BHST
BTCS
BTCS
Q4 25
12.4%
Q3 25
60.3%
22.0%
Q2 25
60.0%
-2.9%
Q1 25
58.2%
7.1%
Q4 24
2.9%
Q3 24
26.5%
Q2 24
69.9%
Q1 24
64.4%
Net Margin
BHST
BHST
BTCS
BTCS
Q4 25
Q3 25
1328.1%
Q2 25
140.0%
Q1 25
-1022.5%
Q4 24
Q3 24
-1223.0%
Q2 24
-1198.9%
Q1 24
2715.3%
EPS (diluted)
BHST
BHST
BTCS
BTCS
Q4 25
$-1.58
Q3 25
$1.30
Q2 25
$0.14
Q1 25
$-0.86
Q4 24
$0.28
Q3 24
$-0.56
Q2 24
$-0.43
Q1 24
$0.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHST
BHST
BTCS
BTCS
Cash + ST InvestmentsLiquidity on hand
$1.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$139.4M
Total Assets
$214.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHST
BHST
BTCS
BTCS
Q4 25
$1.5M
Q3 25
$4.5M
Q2 25
$639.2K
Q1 25
$269.9K
Q4 24
$2.0M
Q3 24
$254.5K
Q2 24
$536.7K
Q1 24
$670.6K
Stockholders' Equity
BHST
BHST
BTCS
BTCS
Q4 25
$139.4M
Q3 25
$225.4M
Q2 25
$31.1M
Q1 25
$20.6M
Q4 24
$34.0M
Q3 24
$25.2M
Q2 24
$33.1M
Q1 24
$39.3M
Total Assets
BHST
BHST
BTCS
BTCS
Q4 25
$214.6M
Q3 25
$298.9M
Q2 25
$40.8M
Q1 25
$21.0M
Q4 24
$38.2M
Q3 24
$26.5M
Q2 24
$33.8M
Q1 24
$39.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHST
BHST
BTCS
BTCS
Operating Cash FlowLast quarter
$-9.8M
Free Cash FlowOCF − Capex
$-9.8M
FCF MarginFCF / Revenue
-138.1%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-15.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHST
BHST
BTCS
BTCS
Q4 25
$-9.8M
Q3 25
$-2.8M
Q2 25
$-1.3M
Q1 25
$-1.9M
Q4 24
$-3.5M
Q3 24
$-695.2K
Q2 24
$-924.1K
Q1 24
$-769.0K
Free Cash Flow
BHST
BHST
BTCS
BTCS
Q4 25
$-9.8M
Q3 25
$-2.8M
Q2 25
$-1.3M
Q1 25
$-1.9M
Q4 24
$-3.5M
Q3 24
Q2 24
Q1 24
FCF Margin
BHST
BHST
BTCS
BTCS
Q4 25
-138.1%
Q3 25
-56.7%
Q2 25
-48.2%
Q1 25
-112.7%
Q4 24
-152.2%
Q3 24
Q2 24
Q1 24
Capex Intensity
BHST
BHST
BTCS
BTCS
Q4 25
0.2%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
Q2 24
Q1 24
Cash Conversion
BHST
BHST
BTCS
BTCS
Q4 25
Q3 25
-0.04×
Q2 25
-0.34×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-0.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BHST
BHST

Segment breakdown not available.

BTCS
BTCS

Builder Plus$5.9M83%
Other$1.2M17%

Related Comparisons